CAS 1400989-25-4

Formel: C21H13ClF3N3O2

InChl: InChI=1S/C21H13ClF3N3O2/c22-19-9-6-15(11-18(19)21(23,24)25)28-20(29)27-14-2-1-3-17(10-14)30-16-7-4-13(12-26)5-8-16/h1-11H,(H2,27,28,29)

InChI Key: QIBWSQJZKMUZAK-UHFFFAOYSA-N

SMILES: C1=CC(=CC(=C1)OC2=CC=C(C=C2)C#N)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F

SC-43

CAS: 1400989-25-4

SC-43

Formel: C₂₁H₁₃ClF₃N₃O₂

Reinheit: ≥98%

Molekulargewicht: 431.8

Ref: 54-BUP04224

1-(4-Chloro-3-(Trifluoromethyl)Phenyl)-3-(3-(4-Cyanophenoxy)Phenyl)Urea

CAS: 1400989-25-4

1-(4-Chloro-3-(Trifluoromethyl)Phenyl)-3-(3-(4-Cyanophenoxy)Phenyl)Urea

Formel: C₂₁H₁₃ClF₃N₃O₂

Reinheit: 99%

Molekulargewicht: 431.8

Ref: 54-PC108739

1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(3-(4-cyanophenoxy)phenyl)urea

CAS: 1400989-25-4

Formel: C₂₁H₁₃ClF₃N₃O₂

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 431.7950

Ref: IN-DA01BRZJ

SC-43

CAS: 1400989-25-4

SC-43 is a potent and orally active agonist of SHP-1 (PTPN6).

Formel: C₂₁H₁₃ClF₃N₃O₂

Reinheit: 98.44%

Farbe und Form: Solid

Molekulargewicht: 431.795

Ref: TM-T8478

SC-43

CAS: 1400989-25-4

1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(3-(4-cyanophenoxy)phenyl)urea

Formel: C₂₁H₁₃ClF₃N₃O₂

Reinheit: 99%

Molekulargewicht: 431.8

Ref: IN-DG767002

1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(3-(4-cyanophenoxy)phenyl)urea

CAS: 1400989-25-4

Reinheit: 99%

Molekulargewicht: 431.7999878

Ref: 10-F866768

1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(3-(4-cyanophenoxy)phenyl)urea

CAS: 1400989-25-4

Tofacitinib is a drug that inhibits the activity of enzymes that are involved in the synthesis of collagen. It is used to treat fibrotic diseases, such as scleroderma, systemic sclerosis, and idiopathic pulmonary fibrosis. Tofacitinib has been shown to be effective in treating renal fibrosis, pancreatic fibrosis and cardiac fibrosis. Tofacitinib also reduces hepatic and hepatic fibrosis.

Formel: C₂₁H₁₃ClF₃N₃O₂

Reinheit: Min. 95%

Molekulargewicht: 431.8 g/mol

Ref: 3D-AGC98925